KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Depreciation and Depletion (2016 - 2026)

Esperion Therapeutics filings provide 8 years of Depreciation and Depletion readings, the most recent being $21000.0 for Q4 2025.

  • On a quarterly basis, Depreciation and Depletion fell 22.22% to $21000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $100000.0, a 58.73% increase, with the full-year FY2025 number at $100000.0, up 58.73% from a year prior.
  • Depreciation and Depletion hit $21000.0 in Q4 2025 for Esperion Therapeutics, down from $26000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $153000.0 in Q1 2021 to a low of $6000.0 in Q4 2023.
  • Median Depreciation and Depletion over the past 5 years was $51000.0 (2023), compared with a mean of $75736.8.
  • Biggest five-year swings in Depreciation and Depletion: plummeted 93.48% in 2023 and later skyrocketed 350.0% in 2024.
  • Esperion Therapeutics' Depreciation and Depletion stood at $153000.0 in 2021, then crashed by 39.87% to $92000.0 in 2022, then plummeted by 93.48% to $6000.0 in 2023, then skyrocketed by 350.0% to $27000.0 in 2024, then dropped by 22.22% to $21000.0 in 2025.
  • The last three reported values for Depreciation and Depletion were $21000.0 (Q4 2025), $26000.0 (Q3 2025), and $27000.0 (Q2 2025) per Business Quant data.